

BUFFALO, NY, July 20, 2026 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leader in advanced molecular imaging technology and comprehensive PET imaging solutions, today announced three new orders for its 64-slice PET-CT systems, each accompanied by multi-year service agreements, from leading nuclear cardiologists whose practices specialize in advanced cardiovascular diagnostics and interventional cardiac care.

Institutional and Insider Ownership 0.0% of Pressure BioSciences shares are owned by institutional investors. 10.8% of Pressure BioSciences shares are owned by company insiders. Comparatively, 17.2% of Positron shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term

Positron (OTCMKTS:POSC - Get Free Report) and AngioDynamics (NASDAQ: ANGO - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Earnings and Valuation This table compares Positron and AngioDynamics"s

Buffalo, NY, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice scanners, along with associated long-term services agreements, to three distinguished nuclear cardiology practices led by nationally recognized physicians specializing in advanced cardiovascular diagnostics and interventional care.

Tenon Medical (NASDAQ: TNON - Get Free Report) and Positron (OTCMKTS:POSC - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Institutional and Insider Ownership 22.7% of Tenon Medical

Positron (OTCMKTS:POSC - Get Free Report) and OPKO Health (NASDAQ: OPK - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Insider and Institutional Ownership 64.6% of OPKO Health

Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has become a reporting company with the U.S Securities and Exchange Commission (SEC). The Company filed a Form 10 registration statement with the SEC containing all required financial statements and disclosures and is now subject to the reporting requirements of the Securities Exchange Act of 1934, as amended. The Company will now be filing its quarterly and annual reports with the SEC, along with current reports to provide updates on material events.

Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging systems and clinical services is pleased to announce a partnership with MedAxiom, the cardiovascular community's premier source for organizational performance solutions.